If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRDL.L Regulatory News (RDL)

  • There is currently no data for RDL

Response to Oaktree

24 Apr 2018 14:58

RNS Number : 9735L
Ranger Direct Lending Fund PLC
24 April 2018
 

24 April 2018

For immediate release

 

 

Ranger Direct Lending Fund plc

("Ranger" or the "Company")

 

Response to Oaktree

 

The Board notes today that Oaktree Capital Management, L.P. ("Oaktree"). has publicly released private correspondence between itself and the Board of Ranger.

 

On 29 January 2018 the Company announced that an independent committee of the Board was conducting a review of the Company's future investment management arrangements and that an Independent Valuer had been appointed to value the Company's portfolio other than the Princeton assets (together, the "Review Process").

 

The Company notes that Oaktree's announcement today merely publishes their letter dated Wednesday 11th April 2018 in which they relayed the "conclusion" that a winding down was the best way forward for the Company. Since the receipt of Oaktree's letter, the Company and its advisors have communicated to Oaktree that all of the relevant issues raised by Oaktree are already being dealt with as part of the Review Process. The only conclusion which can be drawn from this sequence of events is that Oaktree had no serious interest in engaging in the Review Process and their course of action was solely driven by their short-term considerations.

 

With the Review Process completed on schedule, the Board is now engaged in an active and positive discussion with shareholders regarding the future of the Company (including addressing the issues raised in the Oaktree announcement), ahead of the publication of the findings. It is essential to the future of Ranger as a successful public company to achieve sufficient consensus between the Board and shareholders on the Company's future direction. To deliver this outcome requires a detailed and measured dialogue with shareholders.

 

The Company has obligations to its ZDP shareholders. Oaktree's announcement today offers no detail on how those obligations would be met. During a dialogue with Oaktree on 23rd April 2018, in answer to specific requests for information, Oaktree and its advisors were unable to offer the Company any information of substance around a plan for dealing with the contractual rights of the ZDP shareholders or balancing these interests with Ordinary Shareholders.

 

The Review Process has considered the possibility of a full or partial winding down of the Company's activities and returning cash to shareholders. The Board has a duty to act in the interests of all shareholders and, therefore, must seek to achieve the best capital value for the Company's assets and protect dividend flows. In the view of the Board, Oaktree's approach will accomplish neither of those objectives and lead to an extended period of uncertainty for shareholders. In respect of capital value and dividend flows the Board reiterates its view that Oaktree's approach is driven by its own short-term interests.

 

As noted above, the Board's findings on the Review Process including manager selection and investment policy and the independent valuation of the portfolio (other than the Princeton assets) will be published shortly.

 

Contacts:

 

Ranger Direct Lending Fund plc

Christopher Waldron (Chairman)

 

Via Kinmont

Kinmont

Gavin Kelly

 

Tel: +44 (0)20 7087 9134

 

Liberum

Joshua Hughes

 

Tel: +44 (0)20 3100 2000

Redleaf (for media enquiries)

Robin Tozer

Tel: + 44 (0) 20 3757 6867

ranger@redleafpr.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RSPFKQDPNBKDQQB
Date   Source Headline
18th Jun 20187:30 amRNSBoard Changes
12th Jun 20183:09 pmRNSMonthly Update
12th Jun 20183:07 pmRNSNet Asset Value(s)
12th Jun 20187:00 amBUSOaktree Releases Open Letter to Shareholders: Changed Landscape Reinforces Need for Board Change
11th Jun 20183:35 pmRNSNotice of AGM
11th Jun 20187:00 amRNSManagement Review Process Update
8th Jun 20187:00 amBUSOaktree Releases Open Letter to Ranger Shareholders
6th Jun 20184:49 pmRNSResponse to Fourth Oaktree Letter
6th Jun 20187:11 amBUSOaktree Releases Open Letter to Ranger Shareholders
16th May 20184:31 pmRNSNotice of AGM
15th May 20182:46 pmRNSMonthly Update
15th May 20182:34 pmRNSNet Asset Value(s)
14th May 20183:51 pmRNSHolding(s) in Company
8th May 20187:00 amRNSResponse to Third Oaktree Letter
8th May 20187:00 amBUSOaktree Nominates Two Additional Directors for Upcoming Ranger Shareholder Annual General Meeting
4th May 20187:00 amBUSOaktree Releases an Open Letter to Ranger Shareholders following Proposal from RDL Board to Appoint Ares as Investment Manager
1st May 20187:47 amRNSManagement Review Update - Replacement
1st May 20187:18 amRNSManagement Review Update
30th Apr 20187:00 amRNSPortfolio Update
30th Apr 20187:00 amRNSAnnual Financial Report
27th Apr 201810:55 amRNSResponse to Second Oaktree Letter
27th Apr 20187:00 amBUSOaktree Sends Further Letter to Ranger Board of Directors
24th Apr 20182:58 pmRNSResponse to Oaktree
24th Apr 20181:54 pmBUSOaktree Sends Letter to Ranger Board of Directors Regarding Strategic Review
13th Apr 20182:43 pmRNSPortfolio Update
5th Apr 20184:40 pmRNSMonthly Update
5th Apr 20184:36 pmRNSNet Asset Value(s)
3rd Apr 20183:57 pmRNSHolding(s) in Company
3rd Apr 20183:56 pmRNSHolding(s) in Company
12th Mar 20187:48 amRNSPortfolio Update
6th Mar 20184:24 pmRNSMonthly Update
6th Mar 20184:20 pmRNSNet Asset Value(s)
1st Mar 20187:00 amRNSDividend Declaration
27th Feb 20183:06 pmRNSIFRS Implementation
23rd Feb 20182:49 pmRNSHolding(s) in Company
23rd Feb 20182:19 pmRNSHolding(s) in Company
6th Feb 20185:11 pmRNSMonthly Update
6th Feb 20185:09 pmRNSNet Asset Value(s)
6th Feb 20184:21 pmRNSHolding(s) in Company
29th Jan 20188:15 amRNSExternal Management & Princeton Arbitration Update
11th Jan 20184:43 pmRNSPortfolio Update
5th Jan 20183:47 pmRNSMonthly Update
5th Jan 20183:38 pmRNSNet Asset Value(s)
27th Dec 20173:44 pmRNSDirector/PDMR Shareholding
20th Dec 20174:22 pmRNSMonthly Update
20th Dec 20174:20 pmRNSNet Asset Value(s)
15th Dec 20173:38 pmRNSHolding(s) in Company
15th Dec 20177:00 amRNSPortfolio Update
14th Nov 20177:00 amRNSPrinceton - Portfolio Update
14th Nov 20177:00 amRNSDividend Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.